TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

NCT06987123 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: Toripalimab
DRUG: Capecitabine
PROCEDURE: salvage surgery

Sponsor

Sun Yat-sen University